|
CALM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024170E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.244630E-01 |
| Normal-vs-Stage2 |
2.177000E-01 |
| Normal-vs-Stage3 |
4.816800E-01 |
| Normal-vs-Stage4 |
9.517400E-01 |
| Stage1-vs-Stage2 |
7.294000E-01 |
| Stage1-vs-Stage3 |
6.926200E-01 |
| Stage1-vs-Stage4 |
4.536000E-01 |
| Stage2-vs-Stage3 |
5.464600E-01 |
| Stage2-vs-Stage4 |
3.864000E-01 |
| Stage3-vs-Stage4 |
6.322200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.148000E-01 |
| Normal-vs-AfricanAmerican |
4.938500E-02 |
| Normal-vs-Asian |
6.353600E-01 |
| Caucasian-vs-AfricanAmerican |
2.410000E-01 |
| Caucasian-vs-Asian |
8.513800E-01 |
| AfricanAmerican-vs-Asian |
8.286800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.788400E-01 |
| Normal-vs-Female |
1.918380E-02 |
| Male-vs-Female |
6.399700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.928400E-01 |
| Normal-vs-Extreme_Weight |
8.257800E-02 |
| Normal-vs-Obese |
9.087800E-02 |
| Normal-vs-Extreme_Obese |
6.082400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.238980E-01 |
| Normal_Weight-vs-Obese |
1.273580E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.799000E-01 |
| Extreme_Weight-vs-Obese |
9.219200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.615370E-01 |
| Obese-vs-Extreme_Obese |
1.653450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.536100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.797570E-02 |
| Normal-vs-Age(61-80Yrs) |
4.902400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.533600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.645600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.752370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.320000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.187800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.971700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.004300E-03 |
| Normal-VS-Type2 PRCC |
1.812400E-01 |
| Normal-VS-KIRP CIMP |
1.574470E-02 |
| Normal-VS-Unclassified PRCC |
4.304600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.5586999999595E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.554800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.590550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.47109999999396E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.874400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.000200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.342400E-01 |
| Normal-vs-N1 |
4.832200E-01 |
| Normal-vs-N2 |
8.202000E-01 |
| N0-vs-N1 |
2.373200E-01 |
| N0-vs-N2 |
6.669800E-01 |
| N1-vs-N2 |
8.926400E-01 |
|
|
